Parathyroid hormone antagonists with enhanced metabolic properties
US5001223A · kind A · utility
22Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 1989 |
| Grant date | Mar 19, 1991 |
| Priority date | — |
| Expiry date | Mar 2, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of peptide hormone analogues as inhibitors of their respective naturally occurring peptide hormone. The structure of the peptide hormone analogues is exemplified by parathyroid hormone wherein Phe.sup.7 is substituted by NMePhe, D-Phe, desamino Phe, or Met.sup.8 is substituted by NMeMet.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.